The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin
Abstract
Follistatin (FS) inhibits several members of the TGF-beta superfamily, including myostatin (Mstn), a negative regulator of muscle growth. Mstn inhibition by FS represents a potential therapeutic approach of muscle atrophy. The aim of our study was to investigate the mechanisms of the FS-induced muscle hypertrophy. To test the role of satellite cells in the FS effect, we used irradiation to destroy their proliferative capacity. FS overexpression increased the muscle weight by about 37% in control animals, but the increase reached only 20% in irradiated muscle, supporting the role of cell proliferation in the FS-induced hypertrophy. Surprisingly, the muscle hypertrophy caused by FS reached the same magnitude in Mstn-KO as in WT mice, suggesting that Mstn might not be the only ligand of FS involved in the regulation of muscle mass. To assess the role of activin (Act), another FS ligand, in the FS-induced hypertrophy, we electroporated FSI-I, a FS mutant that does not bind Act with high affinity. Whereas FS electroporation increased muscle weight by 32%, the muscle weight gain induced by FSI-I reached only 14%. Furthermore, in Mstn-KO mice, FSI-I overexpression failed to induce hypertrophy, in contrast to FS. Therefore, these results suggest that Act inhibition may contribute to FS-induced hypertrophy. Finally, the role of Act as a regulator of muscle mass was supported by the observation that ActA overexpression induced muscle weight loss (-15%). In conclusion, our results show that satellite cell proliferation and both Mstn and Act inhibition are involved in the FS-induced muscle hypertrophy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Follistatin might enhance SkM hypertrophy due to its ability to bind and neutralize myostatin [184,199], increasing the mass of SkM available for glucose and FFA uptake and oxidation.”
In the citing paper
“FGF21 was determined to increase glucocorticoid action [164] and the secretion of adiponectin [165], while follistatin was found to bind and inactivate myostatin [184] (8), further inhibiting its proinflammatory effects.”
In the citing paper
“Follistatin, on the other hand, by inhibiting myostatin [184] (5), might also contribute to continued lipolysis in WAT.”
Citations
Cites
1 retracted
Pisconti, A., Brunelli, S., Padova, M. D., Palma, C. D., Deponti, D., Baesso, S., Sartorelli, V., Cossu, G., & Clementi, E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507083 · Cited by 107
RetractedRegulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B. C., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 910
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1999) · Nature Genetics · doi:10.1038/10320 · Cited by 471
The transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H., Kull, F. C., & González-Cadavid, N. F. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e221 · Cited by 410
Cited by
Sorted by citations
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Molecular and cellular mechanisms of skeletal muscle atrophy: an update
Fanzani, A., Conraads, V. M., Penna, F., & Martinet, W. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-012-0074-6 · Cited by 386
Skeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 320
Zanou, N., & Gailly, P. L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1330-4 · Cited by 378
Uraemic sarcopenia: aetiology and implications
Fahal, I. H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft070 · Cited by 375
Cancer cachexia: molecular mechanisms and treatment strategies
Setiawan, T., Sari, I. N., Wijaya, Y. T., Julianto, N. M., Muhammad, J. A., Lee, H., Chae, J. H., & Kwon, H. Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01454-0 · Cited by 342
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
Regulation of Muscle Mass by Follistatin and Activins
Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0127 · Cited by 273
Self-citationTGF-β Family Signaling in Mesenchymal DifferentiationPreprint
Grafe, I., Alexander, S., Peterson, J. R., Snider, T. N., Lévi, B., Lee, B., & Mishina, Y. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022202 · Cited by 278
Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery
Asfour, H. A., Allouh, M. Z., & Said, R. S. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217749494 · Cited by 257
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Mendell, J. R., Sahenk, Z., Malik, V., Gomez, A. M., Flanigan, K. M., Lowes, L. P., Alfano, L. N., Berry, K., Meadows, E., Lewis, S., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.200 · Cited by 254
Biomarkers in sarcopenia: A multifactorial approach
Curcio, F., Ferro, G., Basile, C., Liguori, I., Parrella, P., Pirozzi, F., Della‐Morte, D., Gargiulo, G., Testa, G., Tocchetti, C. G., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.09.007 · Cited by 236
Role of Activin A and Myostatin in Human Cancer Cachexia
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., Frateur, L., Maanen, A. G. V., Tréfois, P., Gruson, D., & Thissen, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4318 · Cited by 212
Self-citationRen, H., Gong, D., Jia, F., Xu, B., & Liu, Z. (2016) · Renal Failure · doi:10.3109/0886022x.2015.1132173 · Cited by 204
Hansen, J., Brandt, C., Nielsen, A. R., Hojman, P., Whitham, M., Febbraio, M. A., Pedersen, B. K., & Plomgaard, P. (2011) · Endocrinology · doi:10.1210/en.2010-0868 · Cited by 200
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197
Brooks, N. E., & Myburgh, K. H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00099 · Cited by 206
Sarcopenia – The search for emerging biomarkers
Kalinkovich, A., & Livshits, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.05.001 · Cited by 191
Activin A more prominently regulates muscle mass in primates than does GDF8
Latres, E., Mastaitis, J., Fury, W., Miloscio, L., Trejos, J., Pangilinan, J., Okamoto, H., Cavino, K., Na, E., Papatheodorou, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15153 · Cited by 185
Lee, S., Huynh, T. V., Lee, Y., Sebald, S. M., Wilcox‐Adelman, S. A., Iwamori, N., Lepper, C., Matzuk, M. M., & Fan, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206410109 · Cited by 177
Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
Bączek, J., Silkiewicz, M., & Wojszel, Z. B. (2020) · Nutrients · doi:10.3390/nu12082401 · Cited by 166
A human embryonic limb cell atlas resolved in space and time
Zhang, B., He, P., Lawrence, J. E. G., Wang, S., Tuck, E., Williams, B. A., Roberts, K., Kleshchevnikov, V., Mamanova, L., Bolt, L., et al. (2024) · Nature · doi:10.1038/s41586-023-06806-x · Cited by 143
Latres, E., Pangilinan, J., Miloscio, L., Bauerlein, R., Na, E., Potocky, T. B., Huang, Y., Eckersdorff, M., Rafique, A., Mastaitis, J., et al. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0060-8 · Cited by 143
Myokines and Resistance Training: A Narrative Review
Zunner, B. E. M., Wachsmuth, N. B., Eckstein, M. L., Scherl, L., Schierbauer, J., Haupt, S., Stumpf, C., Reusch, L., & Moser, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073501 · Cited by 146
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
Park, M., & Choi, K. M. (2023) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2023.155577 · Cited by 106
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting
Breitbart, A., Auger‐Messier, M., Molkentin, J. D., & Heineke, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2011 · Cited by 139
Muscle wasting in heart failure: An overview
von Haehling, S., Steinbeck, L., Doehner, W., Springer, J., & Anker, S. D. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.025 · Cited by 129
Zhu, J., Li, Y., Lu, A., Gharaibeh, B., Ma, J., Kobayashi, T., Quintero, A., & Huard, J. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.008 · Cited by 125
Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation
Wang, Q., & McPherron, A. C. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.226001 · Cited by 128
Fusion and beyond: Satellite cell contributions to loading-induced skeletal muscle adaptation
Murach, K. A., Fry, C. S., Dupont‐Versteegden, E. E., McCarthy, J. J., & Peterson, C. A. (2021) · The FASEB Journal · doi:10.1096/fj.202101096r · Cited by 120
Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
Watanabe, H., Enoki, Y., & Maruyama, T. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00513 · Cited by 130
Characterization and Regulation of Mechanical Loading‐Induced Compensatory Muscle Hypertrophy
Adams, G. R., & Bamman, M. M. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110066 · Cited by 123
Loumaye, A., & Thissen, J. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.07.011 · Cited by 112
Self-citationFollistatin Promotes Adipocyte Differentiation, Browning, and Energy Metabolism
Braga, M., Reddy, S. T., Vergnes, L., Pervin, S., Grijalva, V., Stout, D., David, J., Li, X., Tomasian, V., Reid, C. B., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m039719 · Cited by 111
Yamada, M., Tatsumi, R., Yamanouchi, K., Hosoyama, T., SHIRATSUCHI, S., Satô, A., Mizunoya, W., Ikeuchi, Y., Furuse, M., & Allen, R. E. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00449.2009 · Cited by 113
Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1681 · Cited by 106
Sarcopenia in Chronic Kidney Disease
de Souza, V. A., de Oliveira, D., Mansur, H. N., Fernandes, N. M. D. S., & Bastos, M. G. (2015) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20150014 · Cited by 101
Guo, B., Zhang, Z.-K., Liang, C., Li, J., Liu, J., Lu, A., Zhang, B.-T., & Zhang, G. (2017) · Calcified Tissue International · doi:10.1007/s00223-016-0209-4 · Cited by 96
Braga, M., Bhasin, S., Jasuja, R., Pervin, S., & Singh, R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.019 · Cited by 96
Current and Future Pharmacologic Treatment of Sarcopenia
Rolland, Y., Onder, G., Morley, J. E., Guyonnet, S., van Kan, G. A., & Vellas, B. J. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.008 · Cited by 95
Sciorati, C., Clementi, E., Manfredi, A. A., & Rovere, P. Q. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1857-7 · Cited by 99
Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass
Lee, S. (2010) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152210793663748 · Cited by 88
The Role of the Skeletal Muscle Secretome in Mediating Endurance and Resistance Training Adaptations
Leuchtmann, A. B., Adak, V., Dilbaz, S., & Handschin, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709807 · Cited by 84
“, Ericson, J., and Ernfors, P. (2008). Retrograde signaling onto Ret during motor nerve terminal maturation.”
BackgroundInfluentialYan, X., Huang, Y., Jx, Z., Rogers, C. J., Zhu, M.-J., Ford, S. P., Nathanielsz, P. W., & Du, . (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.69 · Cited by 82
β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders
Joassard, O. R., Durieux, A., & Freyssenet, D. G. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.025 · Cited by 85
Role of growth differentiation factor 11 in development, physiology and disease
Zhang, Y., Wei, Y. S., Liu, D., Liu, F., Li, X. A., Pan, L., Pang, Y., & Chen, D. (2017) · Oncotarget · doi:10.18632/oncotarget.20258 · Cited by 84
Bagheri, R., Moghadam, B. H., Church, D. D., Tinsley, G. M., Eskandari, M., Moghadam, B. H., Motevalli, M. S., Baker, J. S., Robergs, R. A., & Wong, A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110869 · Cited by 81
Yates, D. T., Clarke, D. S., Macko, A. R., Anderson, M. J., Shelton, L. A., Nearing, M., Allen, R. E., Rhoads, R. P., & Limesand, S. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272591 · Cited by 86
Sevivas, N., Teixeira, F. G., Portugal, R. V., de Araujo, L. R. R., Carriço, L. F., Ferreira, N., da Silva, M. V., Espregueira‐Mendes, J., Anjo, S. I., Manadas, B. J., et al. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546516657827 · Cited by 80
Circulating Activin A predicts survival in cancer patients
Loumaye, A., de Barsy, M., Nachit, M., Lause, P., Maanen, A. G. V., Tréfois, P., Gruson, D., & Thissen, J. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12209 · Cited by 80
Self-citationBagheri, R., Rashidlamir, A., Motevalli, M. S., Elliott, B., Mehrabani, J., & Wong, A. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04180-z · Cited by 79
Fife, E., Kostka, J., Kroc, Ł., Guligowska, A., Pigłowska, M., Sołtysik, B. K., Kaufman‐Szymczyk, A., Fabianowska‐Majewska, K., & Kostka, T. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0888-y · Cited by 77
Effects of the activin A–myostatin–follistatin system on aging bone and muscle progenitor cells
Bowser, M., Herberg, S., Arounleut, P., Shi, X., Fulzele, S., Hill, W., Isales, C. M., & Hamrick, M. W. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.11.004 · Cited by 75
Anastasilakis, A. D., Koulaxis, D., Kefala, N., Pοlyzos, S. A., Upadhyay, J., Pagkalidou, E., Economou, F. I., Anastasilakis, C. D., & Mantzoros, C. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.002 · Cited by 74
Han, X., Møller, L. L. V., Groote, E. D., Bojsen-Møller, K. N., Davey, J. R., Henríquez‐Olguín, C., Li, Z., Knudsen, J. R., Jensen, T. E., Madsbad, S., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12474 · Cited by 75
Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy
Boursereau, R., Abou-Samra, M., Lecompte, S., Noel, L., & Brichard, S. M. (2018) · BMC Biology · doi:10.1186/s12915-018-0501-z · Cited by 72
Ziaaldini, M. M., Koltai, E., Csende, Z., Goto, S., Boldogh, I., Taylor, A. W., & Radak, Z. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.04.008 · Cited by 72
Vitamin D Signaling in Myogenesis: Potential for Treatment of Sarcopenia
Wagatsuma, A., & Sakuma, K. (2014) · BioMed Research International · doi:10.1155/2014/121254 · Cited by 73
Muscle cell‐derived cytokines in skeletal muscle regeneration
Waldemer, R. J., Kim, D., & Chen, J. (2022) · FEBS Journal · doi:10.1111/febs.16372 · Cited by 79
Morine, K., Bish, L. T., Selsby, J. T., Gazzara, J. A., Pendrak, K., Sleeper, M. M., Barton, E. R., Lee, S., & Sweeney, H. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21743 · Cited by 73
Joassard, O. R., Amirouche, A., Gallot, Y. S., Desgeorges, M. M., Castells, J., Durieux, A., Berthon, P. M., & Freyssenet, D. G. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.019 · Cited by 70
Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model
Rodino‐Klapac, L. R., Janssen, P. M. L., Shontz, K. M., Canan, B. D., Montgomery, C. L., Griffin, D., Heller, K. N., Schmelzer, L., Handy, C. R., Clark, K. R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt342 · Cited by 68
Lactate Stimulates a Potential for Hypertrophy and Regeneration of Mouse Skeletal Muscle
Ohno, Y., Ando, K., Ito, T., Suda, Y., Matsui, Y., Oyama, A., Kaneko, H., Yokoyama, S., Egawa, T., & Goto, K. (2019) · Nutrients · doi:10.3390/nu11040869 · Cited by 67
Regulation of Muscle Growth in Early Postnatal Life in a Swine Model
Rudar, M., Fiorotto, M. L., & Davis, T. A. (2018) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115130 · Cited by 69
Follistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration
Yaden, B. C., Croy, J. E., Wang, Y., Wilson, J. M., Datta‐Mannan, A., Shetler, P. K., Milner, A., Bryant, H. U., Andrews, J., Dai, G., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211169 · Cited by 65
Kobayashi, T., Uehara, K., Ota, S., Tobita, K., Ambrosio, F., Cummins, J. H., Terada, S., Fu, F. H., & Huard, J. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00140.2011 · Cited by 62
Liu, Y., Conboy, M. J., Mehdipour, M., Liu, Y., Tran, T. P., Blotnick, A., Rajan, P., Santos, T. C., & Conboy, I. M. (2017) · Nature Communications · doi:10.1038/s41467-017-00698-y · Cited by 59
Wang, M., Yu, H. M., Kim, Y., Bidwell, C. A., & Kuang, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.040 · Cited by 60
Kalista, S., Schakman, O., Gilson, H., Lause, P., Demeulder, B., Bertrand, L., Pende, M., & Thissen, J. (2011) · Endocrinology · doi:10.1210/en.2011-1687 · Cited by 60
Self-citationHepatokines—A novel group of exercise factors
Weigert, C., Hoene, M., & Plomgaard, P. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2216-y · Cited by 57
Stinckens, A., Georges, M., & Buys, N. (2010) · Animal Genetics · doi:10.1111/j.1365-2052.2010.02144.x · Cited by 58
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54
Pearsall, R. S., Davies, M. V., Cannell, M., Li, J., Widrick, J. J., Mulivor, A. W., Wallner, S., Troy, M., Spaits, M. S., Liharska, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47818-w · Cited by 58
Adiponectin and Skeletal Muscle
Jortay, J., Senou, M., Abou-Samra, M., Noel, L., Robert, A., Many, M.-C., & Brichard, S. M. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.03.035 · Cited by 52
Proteomic signature of muscle atrophy in rainbow trout
Salem, M., Kenney, P. B., Rexroad, C. E., & Yao, J. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.10.014 · Cited by 52
MicroRNAs Regulated by Adiponectin as Novel Targets for Controlling Adipose Tissue Inflammation
Ge, Q., Gérard, J., Noël, L., Scroyen, I., & Brichard, S. M. (2012) · Endocrinology · doi:10.1210/en.2012-1623 · Cited by 52
Iskenderian, A., Liu, N., Deng, Q., Huang, Y. L., Shen, C., Palmieri, K. J., Crooker, R., Lundberg, D. M., Kastrapeli, N., Pescatore, B., et al. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0180-z · Cited by 57
Guardiola, O., Lafuste, P., Brunelli, S., Iaconis, S., Touvier, T., Mourikis, P., Bock, K. D., Lonardo, E., Andolfi, G., Bouché, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204017109 · Cited by 50
Myostatin levels in skeletal muscle of hibernating ground squirrels
Brooks, N. E., Myburgh, K. H., & Storey, K. B. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.055764 · Cited by 49
Treating cancer cachexia to treat cancer
Lee, S., & Glass, D. J. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-2 · Cited by 50
Circulating Follistatin in Patients with Chronic Kidney Disease
Miyamoto, T., Carrero, J. J., Qureshi, A. R., Anderstam, B., Heimbürger, O., Barany, P. F., Lindholm, B., & Stenvinkel, P. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10511110 · Cited by 46
Local induction of adiponectin reduces lipopolysaccharide-triggered skeletal muscle damage
Jortay, J., Senou, M., Delaigle, A., Noel, L., Funahashi, T., Maeda, N., Many, M. C., & Brichard, S. M. (2010) · Endocrinology · doi:10.1210/en.2009-1462 · Cited by 44
Khalafi, M., Aria, B., Symonds, M. E., & Rosenkranz, S. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114272 · Cited by 52
Frost, R. A., & Lang, C. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.012 · Cited by 47
Elliott, B., Herbert, P., Sculthorpe, N. F., Grace, F., Stratton, D., & Hayes, L. D. (2017) · Physiological Reports · doi:10.14814/phy2.13343 · Cited by 43
Pervin, S., Reddy, S. T., & Singh, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653179 · Cited by 42
Zamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 47
Hoogaars, W. M. H., & Jaspers, R. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_8 · Cited by 44
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA
Schumann, C., Nguyen, D. X., Norgard, M. A., Bortnyak, Y., Korzun, T., Chan, S., Lorenz, A. S., Moses, A. S., Albarqi, H. A., Wong, L., et al. (2018) · Theranostics · doi:10.7150/thno.27847 · Cited by 42
Liu, M., Hammers, D. W., Barton, E. R., & Sweeney, H. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166803 · Cited by 41
Suzuki, M., Muro, S., Fukui, M., ISHIZAKI, N., Satô, S., Shiota, T., Endo, K., Suzuki, T., MITSUMA, T., Mishima, M., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2341-3 · Cited by 40
Torregrosa, C., Chorin, F., Beltran, E. E. M., Neuzillet, C., & Cardot‐Ruffino, V. (2022) · Cancers · doi:10.3390/cancers14215402 · Cited by 47
Shi, S., Hoogaars, W. M. H., de Gorter, D. J. J., van Heiningen, S. H., Lin, H. Y.-F., Hong, C. C., Kemaladewi, D. U., Aartsma-Rus, A. M., ten Dijke, P., & Hoen, P. A. C. ’. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.003 · Cited by 40
Role of IGF-I in follistatin-induced skeletal muscle hypertrophy
Barbé, C., Kalista, S., Loumaye, A., Ritvos, O., Lause, P., Ferracin, B., & Thissen, J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00098.2015 · Cited by 40
Self-citationYaden, B. C., Wang, Y. X., Wilson, J. M., Culver, A. E., Milner, A., Datta‐Mannan, A., Shetler, P. K., Croy, J. E., Dai, G., & Krishnan, V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.12.029 · Cited by 39
Lawlor, M. W., Viola, M. G., Meng, H., Edelstein, R. V., Liu, F., Yan, K., Luna, E. J., Lerch-Gaggl, A., Hoffmann, R. G., Pierson, C. R., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.03.003 · Cited by 42
Overcoming Insulin Insufficiency by Forced Follistatin Expression in β -cells of db/db Mice
Zhao, C., Qiao, C., Tang, R., Jiang, J., Li, J., Martin, C. B., Bulaklak, K., Li, J., Wang, D. W., & Xiao, X. (2015) · Molecular Therapy · doi:10.1038/mt.2015.29 · Cited by 37
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review
Supriya, R., Singh, K. P., Gao, Y., Li, F., Dutheil, F., & Baker, J. S. (2021) · Biology · doi:10.3390/biology10121354 · Cited by 40
Nakatani, M., Kokubo, M., Ohsawa, Y., Sunada, Y., & Tsuchida, K. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2010 · Cited by 34
Self-citationGe, Q., Rycken, L., Noël, L., Maury, E., & Brichard, S. M. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2011 · Cited by 34
Metadata
- Authors
- Gilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P.
- Affiliations
- UCLouvain (BE)
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2009-07
- Volume
- 297
- Issue
- 1
- Pages
- E157-E164
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2169876318
- Cited by
- 248
- References
- 48
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 6 · 2023: 13 · 2022: 11 · 2021: 14 · 2020: 16 · 2019: 13 · 2018: 19 · 2017: 17 · 2016: 13 · 2015: 17 · 2014: 22 · 2013: 17 · 2012: 17
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Funders
- Fonds Spéciaux de Recherche
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Meat and Animal Product Quality
- Keywords
- follistatin, muscle hypertrophy, satellite cells, satellite cell proliferation, myostatin, activin, TGF-beta superfamily, muscle atrophy, muscle mass regulation
- MeSH terms
- Animals, Hypertrophy, Male, Muscular Atrophy, Up-Regulation, Rats, Wistar, Mice, Knockout, Activins, Satellite Cells, Skeletal Muscle, Follistatin, Cell Proliferation, Mice, Rats, Myostatin, Rats, Transgenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review